BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1164 related articles for article (PubMed ID: 38473776)

  • 1. Targeted Alpha Therapy for Glioblastoma: Review on In Vitro, In Vivo and Clinical Trials.
    Sabri ME; Moghaddasi L; Wilson P; Saran F; Bezak E
    Target Oncol; 2024 Jun; ():. PubMed ID: 38836953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Therapies for Glioblastoma.
    Rios SA; Oyervides S; Uribe D; Reyes AM; Fanniel V; Vazquez J; Keniry M
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
    Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
    Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapies in Glioblastoma Treatment: Review of Glioblastoma; Current Treatment Options; and Novel Oncolytic Viral Therapies.
    Shah S
    Med Sci (Basel); 2023 Dec; 12(1):. PubMed ID: 38249077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
    Lefranc F; Rynkowski M; DeWitte O; Kiss R
    Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells.
    Kardani K; Sanchez Gil J; Rabkin SD
    Front Cell Infect Microbiol; 2023; 13():1206111. PubMed ID: 37325516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
    Suryawanshi YR; Schulze AJ
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent.
    Ali M; Benfante V; Di Raimondo D; Salvaggio G; Tuttolomondo A; Comelli A
    Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma vaccines: past, present, and opportunities.
    Xiong Z; Raphael I; Olin M; Okada H; Li X; Kohanbash G
    EBioMedicine; 2024 Feb; 100():104963. PubMed ID: 38183840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
    Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Hong W; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
    J Neurooncol; 2024 Feb; 166(3):407-415. PubMed ID: 38153582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma.
    Khan S; Martinez-Ledesma E; Dong J; Mahalingam R; Park SY; Piao Y; Koul D; Balasubramaniyan V; de Groot JF; Yung WKA
    Neurooncol Adv; 2023; 5(1):vdad132. PubMed ID: 38130900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities.
    Boylan J; Byers E; Kelly DF
    Med Res Arch; 2023 Jun; 11(6):. PubMed ID: 38107346
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 59.